Literature DB >> 7535415

Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.

M Hamaguchi1, S Yamagata, A A Thant, H Xiao, H Iwata, T Mazaki, H Hanafusa.   

Abstract

To search for the biochemical properties of cells relevant to transformation by p60v-src, we examined the activities and amounts of metalloproteinase (gelatinase) released from chicken embryonic fibroblasts infected with various mutants of Rous sarcoma virus by zymography and immunoblotting. While nontransforming Src proteins, including cellular p60c-src and its nonmyristylated form, had no stimulatory effect, wild-type p60v-src and the transforming mutant of cellular p60c-src stimulated the secretion and proteolytic activation of metalloproteinases. Moreover, the activation of metalloproteinase secretion strongly correlated with the invasiveness of cells assayed by the modified Boyden Chamber method. Chimeric mutants between v-src and c-src, which are transforming but produce less distinct morphological changes in infected cells, also stimulated the secretion of metalloproteinases as well as wild-type p60v-src. Deletion mutants of v-Src in which varying portions of the NH2-terminal half of p60v-src are deleted stimulated secretion to a level similar to that of wild-type regardless of the degree of morphological change they induce. Together with Src protein, other oncogene products including Yes, Fps, ErbB and Crk were also found to stimulate the secretion of metalloproteinases. Thus, these results suggest that transformation of cells with src and other oncogenes is closely associated with the enhanced secretion of metalloproteinases that may play an important role in tumor invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535415

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth.

Authors:  Elisa Giannoni; Francesca Buricchi; Giovanni Raugei; Giampietro Ramponi; Paola Chiarugi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  Maclurin suppresses migration and invasion of human non-small-cell lung cancer cells via anti-oxidative activity and inhibition of the Src/FAK-ERK-β-catenin pathway.

Authors:  Min Jung Ku; Ji Hyun Kim; Jongsung Lee; Jae Youl Cho; Taehoon Chun; Sang Yeol Lee
Journal:  Mol Cell Biochem       Date:  2015-01-29       Impact factor: 3.396

3.  Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.

Authors:  Y Sohara; N Ishiguro; K Machida; H Kurata; A A Thant; T Senga; S Matsuda; K Kimata; H Iwata; M Hamaguchi
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

4.  Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.

Authors:  A A Thant; A Nawa; F Kikkawa; Y Ichigotani; Y Zhang; T T Sein; A R Amin; M Hamaguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Cancer cachexia: its correlations and causes.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

6.  CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases.

Authors:  T Nakamoto; T Yamagata; R Sakai; S Ogawa; H Honda; H Ueno; N Hirano; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth.

Authors:  Christof R Hauck; Datsun A Hsia; Xose S Puente; David A Cheresh; David D Schlaepfer
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

8.  C-terminal Src kinase controls development and maintenance of mouse squamous epithelia.

Authors:  Reiko Yagi; Satoshi Waguri; Yasuyuki Sumikawa; Shigeyuki Nada; Chitose Oneyama; Satoshi Itami; Christian Schmedt; Yasuo Uchiyama; Masato Okada
Journal:  EMBO J       Date:  2007-02-15       Impact factor: 11.598

9.  RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.

Authors:  Peifen Lu; Junjun Chen; Lihong Yan; Lijun Yang; Litao Zhang; Jie Dai; Zixuan Hao; Tao Bai; Yanfeng Xi; Yahui Li; Zhiming Kang; Jun Xv; Gongqin Sun; Tao Yang
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

10.  CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis.

Authors:  Shu-Mei Yan; Lili Liu; Wan-Yi Gu; Li-Yun Huang; Yi Yang; Yu-Hua Huang; Rong-Zhen Luo
Journal:  J Oncol       Date:  2021-05-18       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.